肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

易感弥漫大B细胞淋巴瘤的生殖系突变

Germline mutations predisposing to diffuse large B-cell lymphoma

原文发布日期:2017-02-17

DOI: 10.1038/bcj.2017.15

类型: Review

开放获取: 是

英文摘要:

摘要翻译: 

原文链接:

文章:

易感弥漫大B细胞淋巴瘤的生殖系突变

Germline mutations predisposing to diffuse large B-cell lymphoma

原文发布日期:2017-02-17

DOI: 10.1038/bcj.2017.15

类型: Review

开放获取: 是

 

英文摘要:

Genetic studies of diffuse large B-cell lymphomas (DLBCLs) in humans have revealed numerous targets of somatic mutations and an increasing number of potentially relevant germline alterations. The latter often affect genes involved in DNA repair and/or immune function. In general, defects in these genes also predispose to other conditions. Knowledge of these mutations can lead to disease-preventing measures in the patient and relatives thereof. Conceivably, these germline mutations will be taken into account in future therapy of the lymphoma. In other hematological malignancies, mutations originally found as somatic aberrations have also been shown to confer predisposition to these diseases, when occurring in the germline. Further interrogations of the genome in DLBCL patients are therefore expected to reveal additional hereditary predisposition genes. Our review shows that germline mutations have already been described in over one-third of the genes that are somatically mutated in DLBCL. Whether such germline mutations predispose carriers to DLBCL is an open question. Symptoms of the inherited syndromes associated with these genes range from anatomical malformations to intellectual disability, immunodeficiencies and malignancies other than DLBCL. Inherited or de novo alterations in protein-coding and non-coding genes are envisioned to underlie this lymphoma.

 

摘要翻译: 

对人类弥漫性大B细胞淋巴瘤(DLBCL)的遗传学研究揭示了体细胞突变的众多靶点以及越来越多的潜在相关种系突变。后者通常影响涉及DNA修复和/或免疫功能的基因。通常,这些基因的缺陷也会增加其他疾病的风险。了解这些突变可以导致患者及其亲属采取疾病预防措施。可以想象,这些种系突变将在未来淋巴瘤治疗中被考虑在内。在其他血液恶性肿瘤中,最初发现为体细胞畸变的突变,当发生在种系时,也被证明会赋予对这些疾病的易感性。因此,预计对DLBCL患者基因组的进一步研究将揭示更多的遗传易感基因。我们的综述显示,在DLBCL中体细胞突变的基因中,已有超过三分之一的基因被描述有种系突变。这些种系突变是否使携带者易患DLBCL是一个悬而未决的问题。与这些基因相关的遗传综合征的症状范围从解剖畸形到智力残疾、免疫缺陷和除DLBCL以外的恶性肿瘤。编码和非编码基因的遗传性或新生突变被认为是这种淋巴瘤的基础。

 

原文链接:

Germline mutations predisposing to diffuse large B-cell lymphoma

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……